BioLife Solutions, Inc. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net
BioLife Solutions, Inc. (BLFS) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss · last filed 2024-02-29
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2022-12-31 was $0.00.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2021-12-31 was $0.00.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2021-09-30 was $6.45M.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2023 was $0.00.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2021 was $6.45M.
- BioLife Solutions, Inc. business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.45M derived: sum of 2 quarters · filed 2024-02-29 | $6.45M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $6.45M 10-Q · filed 2022-11-09 | $6.45M 10-Q · filed 2022-11-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $10.11M derived: sum of 2 quarters · filed 2021-03-31 | $10.11M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $10.11M 10-Q · filed 2020-11-09 | $10.11M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |